These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740 [TBL] [Abstract][Full Text] [Related]
5. Huntington's disease: translating a CAG repeat into a pathogenic mechanism. MacDonald ME; Gusella JF Curr Opin Neurobiol; 1996 Oct; 6(5):638-43. PubMed ID: 8937828 [TBL] [Abstract][Full Text] [Related]
6. Lessons from animal models of Huntington's disease. Rubinsztein DC Trends Genet; 2002 Apr; 18(4):202-9. PubMed ID: 11932021 [TBL] [Abstract][Full Text] [Related]
7. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219 [TBL] [Abstract][Full Text] [Related]
8. Modeling Huntington's disease in cells, flies, and mice. Sipione S; Cattaneo E Mol Neurobiol; 2001 Feb; 23(1):21-51. PubMed ID: 11642542 [TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303 [TBL] [Abstract][Full Text] [Related]
10. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. Menalled LB; Sison JD; Wu Y; Olivieri M; Li XJ; Li H; Zeitlin S; Chesselet MF J Neurosci; 2002 Sep; 22(18):8266-76. PubMed ID: 12223581 [TBL] [Abstract][Full Text] [Related]
11. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013 [TBL] [Abstract][Full Text] [Related]
12. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824 [TBL] [Abstract][Full Text] [Related]
13. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Kennedy L; Shelbourne PF Hum Mol Genet; 2000 Oct; 9(17):2539-44. PubMed ID: 11030759 [TBL] [Abstract][Full Text] [Related]
14. The early cellular pathology of Huntington's disease. Li XJ Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117 [TBL] [Abstract][Full Text] [Related]
15. The selective vulnerability of nerve cells in Huntington's disease. Sieradzan KA; Mann DM Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997 [TBL] [Abstract][Full Text] [Related]
17. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Bradford J; Shin JY; Roberts M; Wang CE; Li XJ; Li S Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22480-5. PubMed ID: 20018729 [TBL] [Abstract][Full Text] [Related]